MLM vs ZYME · P/E 36, rev $6.15B vs rev $76.3M
Martin Marietta Materials Inc (MLM) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Martin Marietta Materials Inc (MLM) is a building materials company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported MLM revenue for 2025-12-31 was $6.15B. Net income was $1.14B. Revenue was down 5.9% from 2024-12-31 to 2025-12-31. MLM currently screens at market cap $34.63B and trailing P/E 36.2.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
MLM currently screens at market cap $34.63B and trailing P/E 36.2. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the MLM and ZYME stock pages for the full models.
Not investment advice.